Osteo Relief Institute: The Pain Relief Haven

Arthritis is very common but it remains enigmatic to many people. It is not a single disease but a joint disease in general. According to the research carried out recently, there are over 100 different types of arthritis. In the United States alone, 50 million adults are estimated to have various forms of this disease. Osteoarthritis is a common type of arthritis. Some of the indicators of Osteoarthritis is the degeneration of cartilage that makes the bones to rub against each other causing a lot of pain and subsequently swelling and stiffness. As time goes by, osteoarthritis may deteriorate to a chronic stage. The condition has no cure; however, there are various available measures for managing the pain. The causes of osteoarthritis include excess weight, previous injury, family history and age. Since arthritis has no cure, there is an array of self-management strategies that one should employ for maximum control and relief. They include exercise, daily routine and medical option (HealthGrades).


Osteo Relief institute is based in New Jersey, and it strives to offer reliable solutions for pain relief that are non-surgical in aspect. Osteo Relief Institute assists the patients regain their normal movement and pain relief. The institute comprises of a group of board certified physicians and physical therapists that are highly qualified and who believe that the patient comes first. The main goal of Osteo Relief Institute is to make sure that the patient does not undergo surgery. The use of FDA approved and cleared technologies ensures that the patients derive solutions that they have been looking for. The goal is to provide the patient with the most advanced and effective treatments available.

Osteo Relief Institute strives to use sophisticated technology to offer world-class pain relief procedures. The staff is highly qualified and skilled, and thus offers unmatched service to the patients. The physicians are patients centred and are always ready to offer maximum attention to every person. Osteo Relief Institute offers a no charge introductory screening. The institute targets to make people healthy and live well with no pain. The physicians offer nonsurgical knee pain relief injections to help with the OA.

More here | LinkedIn | Facebook

What the New Research Findings by Dr. Shiva Gopal Vasishta Mean for MS Patients

Dr. Shiva Gopal Vasishta is a doctor in New Jersey who specializes in neurology and psychiatry. He studied at Government Medical College and later did his residency at Boston City Hospital. Dr. Shiva has gained almost 40 years of experience in the field with 20 years as a practising doctor and currently works at Eastern Neurodiagnostic Associates but also tends to patients at Kennedy Health System Cherry Hill. Dr. Shiva is one of the doctors committed to find cures to neurological diseases and disorders such as multiple sclerosis (MS).

His practice is one of the few places that conduct transparent transactions when it comes to remitting the medical expenses to the patient’s insurances. The practice accepts most of the insurances companies’ cards and only charges the amounts approved per Medicare policies. The practice’s common language of use is English but uses Spanish too in order to help the patients of Spanish origin.

Dr. Shiva Gopal is among the doctors who were involved in the neurological research whose results have been released most recently. The research involved 24 patients of ages 26-52 suffering from relapsing-remitting Multiple Sclerosis. In the research the patients received an autologous hematopoietic cell transplant after their high dosage of high-dose immunosuppressive therapy. 69% of the patients’ conditions stabilized.  In two of the worst cases the patients died but their deaths were later confirmed to have nothing to do with the experiment although a few caught infections due to their low immune systems.

Even though the findings need further testing, it is certain that the one-time treatment is more effective than the continuous treatment with the MS drugs and this has shone new light to both the patients and the doctors.